Lydia Jordan
Principal Investigator CGT Supply Chain • GlaxoSmithKline
Lydia Jordan is a Principal Investigator in CGT Supply Chain at GSK. She is responsible for implementation, compliance, and management of Cell Therapy Operations in the US and Canada markets for cell and gene therapy clinical trials.
Her 15+ year career at GSK spans drug discovery, CMC and clinical supply with a focus on innovations and advancement in medicine development.
Also Speaking
Steven B. Miller
30 December 2022
David Sourdive
Co-Founder and Executive Vice President CMC & Manufacturing • Cellectis
27 October 2022
Also Speaking
Investor List
Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023
